🇺🇸 FDA
Patent

US 8816046

Compositions and methods for CaMKII inhibitors and uses thereof

granted A61KA61K38/45A61K47/543

Quick answer

US patent 8816046 (Compositions and methods for CaMKII inhibitors and uses thereof) held by The Regents of the University of Colorado, a Body Corporate expires Mon Aug 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue Aug 26 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K38/45, A61K47/543, A61K47/64, A61P